Corrigendum to “The changing landscape of Heart Failure: translating management into the modern era” [European Journal of Internal Medicine (2026) 106633]

The authors regret that in Figure 1 the name of the drug Sacubitril/Valsartan was incorrectly reported as sacubutril valsartan. This was a typographical error, and the figure has now been corrected as below. This correction does not affect the scientific conclusions of the article.